Product
ION-682884
1 clinical trial
2 indications
Indication
Healthy Control ParticipantsIndication
hATTR AmyloidosisClinical trial
This Was a Phase 1/2, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study Conducted at a Single Center for the Healthy Volunteer Cohorts in up to 56 Participants. It Consisted of 1 Single-dose Cohort and 3 Multiple-dose Cohorts (n = 12 Per Cohort, 10 Active:2 Placebo). The Open-label, hATTR Patient Cohort Portion of the Study Was Conducted at Multiple Centers.Status: Completed, Estimated PCD: 2020-02-20